Treatment of peritoneal carcinomatosis of colorectal origin

Andrea Cercek; James C Cusack Jr; David P Ryan

doi:10.14694/EdBook_AM.2015.35.e208

Treatment of peritoneal carcinomatosis of colorectal origin

Am Soc Clin Oncol Educ Book. 2015:e208-11. doi: 10.14694/EdBook_AM.2015.35.e208.

Authors

Andrea Cercek¹, James C Cusack Jr¹, David P Ryan¹

Affiliation

¹ From the Memorial Sloan Kettering Cancer Center, New York, NY; Massachusetts General Hospital, Boston, MA.

PMID: 25993175
DOI: 10.14694/EdBook_AM.2015.35.e208

Abstract

The management of peritoneal carcinomatosis from colon cancer remains a controversial issue. Peritoneal carcinomatosis is associated with worse survival and has led to an aggressive treatment that combines surgery and intraperitoneal chemotherapy (IPC). This review will describe the rationale behind this treatment and the current controversy surrounding it.

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Colorectal Neoplasms / pathology*
Colorectal Neoplasms / therapy*
Combined Modality Therapy
Humans
Neoplasm Metastasis
Peritoneal Neoplasms / pathology
Peritoneal Neoplasms / secondary*
Peritoneal Neoplasms / therapy*
Randomized Controlled Trials as Topic